Catalyst Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
CN2
US14888U1016
Pharmaceuticals
|
Market Closed -
Deutsche Boerse AG
11:30:58 14/07/2026 am IST
|
5-day change | 1st Jan Change | ||
| 27.30 EUR | +2.63% |
|
-.--% | +35.01% |
| 03/08 | CDP targets new defense acquisitions after T-Defence deal - sources | RE |
| 03/08 | CDP's new chapter, a push for global companies | AN |
| Market Cap | 385.5Cr 332.96Cr 312.88Cr 284.55Cr 534.97Cr 37TCr 543.79Cr 3.67TCr 1.43TCr 18TCr 1.45TCr 1.42TCr 61TCr | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 314.86Cr 271.95Cr 255.54Cr 232.41Cr 436.94Cr 30TCr 444.14Cr 2.99TCr 1.17TCr 15TCr 1.18TCr 1.16TCr 50TCr | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +2.63% | ||
| 3 months | +4.20% | ||
| 6 months | +39.50% | ||
| Current year | +35.01% |
| Current year | 18.96 |  | 27.4 |
| 1 year | 16.15 | | 27.4 |
| 3 years | 10.93 | | 27.4 |
| 5 years | 4.12 | | 27.4 |
| 10 years | 0.66 | | 27.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 15/07/2026 | |
Massimo Marin
BRD | Director/Board Member | - | 15/07/2026 |
Enrica Dogali
BRD | Director/Board Member | - | 15/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | -.--% | - | - | 385.5Cr | |
| -0.31% | +2.44% | +41.97% | -0.61% | 8.02TCr | |
| -1.02% | -0.51% | -2.54% | +26.80% | 5.07TCr | |
| -3.10% | -4.84% | +9.26% | +158.46% | 4.69TCr | |
| -0.74% | +3.26% | -49.46% | -48.10% | 4.63TCr | |
| -0.39% | +0.91% | +55.50% | -23.07% | 3.1TCr | |
| -0.52% | +7.01% | +137.24% | -36.68% | 2.53TCr | |
| -0.30% | -0.33% | +39.46% | +84.18% | 2.44TCr | |
| -1.42% | -1.11% | -2.29% | +189.51% | 2.08TCr | |
| -1.83% | -2.82% | +61.91% | +105.60% | 1.61TCr | |
| Average | -0.70% | +1.44% | +32.34% | +50.68% | 3.8TCr | |
| Weighted average by Cap. | -0.98% | +1.13% | +24.82% | +36.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49Cr 42Cr 40Cr 36Cr 68Cr 4.7TCr 69Cr 467.63Cr 182.84Cr 2.35TCr 184.62Cr 180.61Cr 7.82TCr | 59Cr 51Cr 48Cr 43Cr 82Cr 5.63TCr 83Cr 560.11Cr 219Cr 2.82TCr 221.14Cr 216.34Cr 9.37TCr |
| Net income | 16Cr 14Cr 13Cr 12Cr 23Cr 1.57TCr 23Cr 155.85Cr 61Cr 784.78Cr 62Cr 60Cr 2.61TCr | 21Cr 19Cr 17Cr 16Cr 30Cr 2.05TCr 30Cr 203.82Cr 80Cr 1.03TCr 80Cr 79Cr 3.41TCr |
| Net Debt | -51Cr -44Cr -42Cr -38Cr -71Cr -4.92TCr -73Cr -489.15Cr -191.25Cr -2.46TCr -193.12Cr -188.93Cr -8.18TCr | -71Cr -61Cr -57Cr -52Cr -98Cr -6.75TCr -100Cr -671.75Cr -262.65Cr -3.38TCr -265.21Cr -259.45Cr -11TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
- CN2 Stock
Select your edition
All financial news and data tailored to specific country editions
